Search
Now showing items 21-30 of 32
-
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update
ESMO Open, European Society for Medical Oncology, 10-2021, 6; 5, 100273Compte-rendu et recension critique d'ouvragefulltext -
Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
Genome Medicine, BioMed Central, 12-2021, 13; 1Article dans une revue scientifiquefulltext -
Real life experience of mycophenolate mofetil monotherapy in liver transplant patients
Clinics and Research in Hepatology and Gastroenterology; Clinics and Research in Hepatology and Gastroenterology, Elsevier, 01-01-2021, 45; 1, 101451Compte-rendu et recension critique d'ouvragefulltext -
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
The Lancet Digital Health, Elsevier, 01-2021, 397; 10272, 375-386Compte-rendu et recension critique d'ouvragefulltext -
Repeat stereotactic radiosurgery for progressive vestibular schwannomas after previous radiosurgery: a systematic review and meta-analysis
Neurosurgical Review, Springer Verlag, 2021, 44; 6, 3177 - 3188Compte-rendu et recension critique d'ouvragefulltext -
Deep Learning on Chest X-ray Images to Detect and Evaluate Pneumonia Cases at the Era of COVID-19
Signal & Image Processing : An International Journal, AIRCC Publishing Corporation, 07-2021, 45; 7, 75Compte-rendu et recension critique d'ouvragefulltext -
Microsurgical resection of fronto-temporo-insular gliomas in the non-dominant hemisphere, under general anesthesia using adjunct intraoperative mri and no cortical and subcortical mapping: a series of 20 consecutive patients
Scientific Reports, 26-03-2021, 11, 6994Article dans une revue scientifiquefulltext -
Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma.
EClinicalMedicine, 23-05-2021, 35, 100844Compte-rendu et recension critique d'ouvragefulltext -
Loss of hepatocyte identity following aberrant YAP activation: a key mechanism in alcoholic hepatitis.
Journal of Hepatology, Elsevier, 12-06-2021, 75; 4, 912-923Compte-rendu et recension critique d'ouvragefulltext -
Outcome of early stage Merkel carcinoma treated by exclusive radiation: a study of 53 patients
Radiation Oncology, 01-01-2021, 16, 90Compte-rendu et recension critique d'ouvragefulltext